Everest Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2026 ,inter alia, to consider and approve to consider inter alia unaudited financial results for the quarter and half year ended September 30, 2026

Date: 09th November, 2026 Listing Compliance Department, BSE Limited (BSE), Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400 001. Scrip Code: 524790 Sub: Prior intimation of Board Meeting under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and closure of Trading Window Dear Sir/Madam, Pursuant to Regulation 29(1)(a) read with Regulation 29(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a meeting of the Board of Directors of Everest Organics Limited (“the Company”) is scheduled to be held on Thursday, November 12, 2026, inter-alia, to consider and approve the Unaudited Financial Results (Standalone) of the Company for the quarter and half year ended September 30, 2026, along with the Limited Review Report of the Statutory Auditors on the aforesaid results. Further, pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company’s Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons, the Trading Window for dealing in the securities of the Company has been closed for all Designated Persons and their immediate relatives from Thursday, October 1, 2026 and shall remain closed till 48 hours after the declaration of the said financial results to the Stock Exchanges. Kindly take the same on record. Thanking you. Yours sincerely, For Everest Organics Limited Dr. Sirisha Srikakarlapudi Managing Director & CEO DIN: 06921012